CSIMarket Company Name, Ticker, Suppliers, else..
 

Abiomed Inc   (NASDAQ: ABMD)

Abiomed Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ABMD Sales vs. its Competitors Q2 2022


Comparing the current results to its competitors, Abiomed Inc reported Revenue increase in the 2 quarter 2022 by 7.16 % year on year.
The sales growth was above Abiomed Inc 's competitors' average revenue growth of 0.94 %, achieved in the same quarter.

• List of ABMD Competitors

With a net margin of 39.91 % Abiomed Inc achieved higher profitability than its competitors.

• More on ABMD Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Abiomed Inc Net Income in the 2 quarter 2022 grew year on year by 86.35%, while most of its competitors have experienced a net loss.

<<  ABMD Stock Performance Comparisons





  

Overall company Market Share Q2 2022
With revenue growth of 7.16 % within Overall company, Abiomed Inc achieved improvement in market share, within Overall company to approximately 0.96 %.
<<  More on ABMD Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Abiomed Inc




Jin Medical International Ltd
Share Performance



-54.22%
This Year
Jin Medical International Ltd
Profile

Jin Medical International Ltd. operates in the medical technology sector in China through a variable interest entity (VIE).

More about Jin Medical International Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 322.487 mill. $ 20.687 mill. $ 1.381 mill.


Edwards Lifesciences Corporation
Share Performance



+1.07%
This Quarter
Edwards Lifesciences Corporation
Profile

Edwards Lifesciences Corporations business model focuses on the development and commercialization of advanced medical technologies that enhance the diagnosis and treatment of heart disease, emphasizing innovative heart valves and critical care monitoring solutions. The company serves a diverse customer base, including hospitals and direct-to-patient markets, with a strong commitment to improving patient outcomes and quality of life.

More about Edwards Lifesciences Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 50,118.352 mill. $ 6,512.500 mill. $ 1,003.600 mill.


Cvrx inc
Share Performance



+10.00%
30 Days
Cvrx inc
Profile

Cvrx Inc. operates on a business model focused on developing medical devices to treat cardiovascular diseases. The company focuses on developing implantable neurostimulation technologies to improve heart function and manage hypertension. They aim to provide innovative solutions that enable better patient outcomes and ultimately revolutionize the field of cardiovascular therapy.

More about Cvrx inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 75.834 mill. $ 60.164 mill. $ -51.968 mill.


Cardiovascular Systems Inc
Share Performance



+48.48%
This Year
Cardiovascular Systems Inc
Profile

Cardiovascular Systems Inc operates a business model focused on providing innovative medical technologies and solutions for the treatment of cardiovascular diseases.

More about Cardiovascular Systems Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 793.271 mill. $ 239.843 mill. $ -37.867 mill.


Boston Scientific Corporation
Share Performance



-15.84%
30 Days
Boston Scientific Corporation
Profile

Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.

More about Boston Scientific Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 64,696.125 mill. $ 20,616.000 mill. $ 3,559.000 mill.

35 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Abiomed Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Abiomed Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.